CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Immunochemotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Fludarabine (FIT Cyclophosphamide (C) and MabCampath (Cam) (FCCam) in Previously Untreated Patients (pts) with Advanced B-Chronic Lymphocytic Leukemia (B-CLL) : Experience On Safety and Efficacy within a Randomised Multicenter Phase III Trial of the french Cooperative Group On CIA, and WM (FCGCLL/MW) and the "Groupe Ouest-Est d'Etudes Des Leucemies Aigues Et Autres Maladies Du sang" (GOELAMS): CLL2007FMP (for fit medically patients)
Author
51st Annual Meeting of the American-Society-of-Hematology
Aurran Therese
+17 more
Bene Marie-Christine
Casasnovas Olivier
Cazin Bruno
Chevret Sylvie
Corront Brigitte
Cymbalista Florence
Delepine Roselyne
Delmer Alain
Feugier Pierre
Leblond Veronique
Lepretre Stephane
Mahe Beatrice
Maisonneuve Herve
Royer Bruno
Tournihlac Olivier
Van Den Neste Eric
Vaudaux Sandrine
Publication venue
Amer Soc Hematology
Publication date
01/01/2009
Field of study
No full text
DIAL UCLouvain